Clinical trial
Blockade of the Renin-angiotensin-aldosterone System in Patients With ARVD: a Double-blind Multicentre Prospective Randomized Study.
NCT03593317 is registered in ClinicalTrials.gov with Hospices Civils de Lyon as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Blockade of the Renin-angiotensin-aldosterone System in Patients With ARVD: a Double-blind Multicentre Prospective Randomized Study.
- Lead sponsor
- Hospices Civils de Lyon
- Phase
- Phase 2
- Overall status
- Recruiting
- Start date
- December 20, 2024
- Completion date
- December 31, 2029
- Enrollment
- 120 (estimated)
- Sites
- 13
Conditions
As the registry lists them; a condition with its own page is linked.